Sloan-Kettering Institute

In more than 100 laboratories, our scientists are conducting innovative research to advance understanding in the biological sciences and improve human health.

Learn more »
Growing Science: A Decade Devoted to Advancing Cancer Research at the Sloan-Kettering Institute »

Lab Heads

Select...
Allis, David
Funabiki, Hironori
Leibler, Stanislas
Ryan, Timothy A.
Weinstein, Harel
Pictured: Eric Pamer
Researchers Shed Light on Possible Cause of Infections in Cancer Patients

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan-Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.

Pictured: Eric Pamer
Pictured: Structural formula of IBNtxA
Findings Could Lead to the Development of a New Painkiller

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

Pictured: Structural formula of IBNtxA
Pictured: Gabriela Chiosis
Out of the Lab and into the World: Hsp90 Inhibitor, a New Cancer Drug

A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan-Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.

Pictured: Gabriela Chiosis

Upcoming Programs & Events

Seminar
Interplay Between Transcription Factors and Chromatin During Motor Neuron Specification
Monday, February 6, 2012 - 12:00 PM–1:00 PM
Seminar
Induction and Inhibition of Type I Interferon by RNA Viruses
Monday, February 6, 2012 - 1:30 PM–2:30 PM
Seminar
Watching Single Ribosome Translation in Real Time: A Quantitative Study of Ribosome Helicase Activity
Tuesday, February 7, 2012 - 11:00 AM–12:00 PM
See all »